Beijing Biostar Pharmaceuticals Co., Ltd.
- Biotech or pharma, therapeutic R&D
Beijing Biostar is a synthetic biology-driven biopharmaceutical company committed to developing innovative drugs in oncology globally. Our BD priority is to secure a global or ex-China partner for Utidelone Capsule, a differenciated epothilone analog (Phase II), which demonstrated excellent efficacy and safety profile in both western and Chinese patient population, key lead indications including gastric cancer, ovarain cancer and breast cancer.